How I treat elderly patients with plasma cell dyscrasias.

Gavriatopoulou, Maria; Fotiou, Despoina; Ntanasis-Stathopoulos, Ioannis; Kastritis, Efstathios; Terpos, Evangelos; Dimopoulos, Meletios Athanasios

Gavriatopoulou, Maria; Fotiou, Despoina; Ntanasis-Stathopoulos, Ioannis; Kastritis, Efstathios; Terpos, Evangelos; Dimopoulos, Meletios Athanasios.

Afiliação

Gavriatopoulou M; Alexandra Hospital, Oncology Department, Department of Therapeutics, National and Kapodistrian University of Athens, Athens 11528, Greece.
Fotiou D; Alexandra Hospital, Oncology Department, Department of Therapeutics, National and Kapodistrian University of Athens, Athens 11528, Greece.
Ntanasis-Stathopoulos I; Alexandra Hospital, Oncology Department, Department of Therapeutics, National and Kapodistrian University of Athens, Athens 11528, Greece.
Kastritis E; Alexandra Hospital, Oncology Department, Department of Therapeutics, National and Kapodistrian University of Athens, Athens 11528, Greece.
Terpos E; Alexandra Hospital, Oncology Department, Department of Therapeutics, National and Kapodistrian University of Athens, Athens 11528, Greece.
Dimopoulos MA; Alexandra Hospital, Oncology Department, Department of Therapeutics, National and Kapodistrian University of Athens, Athens 11528, Greece.

Aging (Albany NY) ; 10(12): 4248-4268, 2018 12 18.

Article em En | MEDLINE | ID: mdl-30568029

Assuntos

Paraproteinemias/tratamento farmacológico; Idoso; Fragilidade; Avaliação Geriátrica; Humanos

Palavras-chave

AL amyloidosis; Multiple Myeloma; Waldenstrom Macroglobulinemia; elderly patients; frailty

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paraproteinemias Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google